Literature DB >> 6954952

Multiple forms of phenolsulphotransferase in human tissues: selective inhibition by dichloronitrophenol.

G Rein, V Glover, M Sandler.   

Abstract

Evidence is presented for two functional forms of phenolsulphotransferase in human tissues: (1) activity ratios, using dopamine and phenol as substrates, varied 30-fold between different tissues, whereas the dopamine to tyramine activity ratio was relatively constant; (2) incubation at 37 degrees caused a selective decrease in activity towards dopamine compared with phenol; and (3) phenol sulphoconjugation was selectively inhibited by dichloronitrophenol and pentachlorophenol compared with that of dopamine and tyramine. The two forms, which have been designated M (monoamines) and P (phenol), were both present in platelets, jejunum, adrenal and brain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6954952     DOI: 10.1016/0006-2952(82)90493-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

1.  Genetic polymorphisms and linkage disequilibrium of sulfotransferase SULT1A1 and SULT1A2 in a Korean population: comparison of other ethnic groups.

Authors:  Kyoung-Ah Kim; Sook-Young Lee; Pil-Whan Park; Jong-Myung Ha; Ji-Young Park
Journal:  Eur J Clin Pharmacol       Date:  2005-08-26       Impact factor: 2.953

2.  Stereoselective metabolism of RS-albuterol in humans.

Authors:  T Walle; E A Eaton; U K Walle; G R Pesola
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

3.  Red wine contains a potent inhibitor of phenolsulphotransferase.

Authors:  J T Littlewood; V Glover; M Sandler
Journal:  Br J Clin Pharmacol       Date:  1985-02       Impact factor: 4.335

4.  Sulphate conjugation of beta 2-adrenoceptor stimulating drugs by platelet and placental phenol sulphotransferase.

Authors:  R J Sodha; H Schneider
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

Review 5.  Urinary MHPG sulfate as a marker of central norepinephrine metabolism: a commentary.

Authors:  L Peyrin
Journal:  J Neural Transm Gen Sect       Date:  1990

6.  Stereoselective sulphate conjugation of racemic terbutaline by human liver cytosol.

Authors:  T Walle; U K Walle
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

7.  Platelet phenolsulphotransferase activity in Parkinson's disease.

Authors:  V Glover; A J Lees; C Ward; G M Stern; M Sandler
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

8.  Human platelet phenolsulphotransferase M and P: substrate specificities and correlation with in vivo sulphoconjugation of paracetamol and salicylamide.

Authors:  S M Bonham Carter; G Rein; V Glover; M Sandler; J Caldwell
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

9.  Platelet abnormalities in aggressive subjects with mental deficiency.

Authors:  D Marazziti; L Palego; S Silvestri; S Presta; C Balestri; A Batistini; L Conti
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

10.  Genetic polymorphism for human platelet thermostable phenol sulfotransferase (TS PST) activity.

Authors:  R A Price; R S Spielman; A L Lucena; J A Van Loon; B L Maidak; R M Weinshilboum
Journal:  Genetics       Date:  1989-08       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.